How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease.
about
Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylationThe Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegenerationStructure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPaseProtein Kinases and Parkinson's DiseaseAssessment of the progression of Parkinson's disease: a metabolic network approach.A common genetic factor for Parkinson disease in ethnic Chinese population in TaiwanThe parkin mutant phenotype in the fly is largely rescued by metal-responsive transcription factor (MTF-1)Genetic neuropathology of Parkinson's disease.Prolonged toxicokinetics and toxicodynamics of paraquat in mouse brain.Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, alpha-synuclein, and tau.The genetics of neurodegenerative diseases.Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease.α-Synuclein nonhuman primate models of Parkinson's disease.PINK1 overexpression protects against C2-ceramide-induced CAD cell death through the PI3K/AKT pathway.The impact of genetic research on our understanding of Parkinson's diseaseMitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?Neurodegenerative disease: pink, parkin and the brain.
P2860
Q24316270-ABF75C62-832B-415A-A167-07A394EBD8F7Q24322927-5832A66F-F6F0-4033-8665-FFAB79ECB5F1Q27649733-3BB06CFA-B2EA-4801-841C-586C8C547486Q28067636-D3144CF6-401D-4A13-8018-111E7BAE02C2Q31130371-66F5EECF-F1D5-4094-8A6A-9C1CA92AF5D2Q33267533-E4DC71DD-A854-4826-80DB-58002FA10829Q34169067-4BA6A572-F1A8-4356-8FE0-FD605B297635Q34825312-CA816779-DE20-4153-A36B-16DBFE928ECEQ36064964-88E54FC7-BFBB-4CDC-B261-A3F5662F5AEFQ36325784-D54737DC-8A88-4E96-AAEB-DC01E53A3C42Q36521941-5F57A7B7-C492-4774-BBCE-0D3CE9E27F9BQ36616362-EBD4CCAB-704E-449F-ABC0-6B1FD7053900Q37225356-C1153EF5-21BF-469A-A5EC-2840F8D373E9Q37241917-9B4BE009-6E34-4CD2-BCE1-BDD9BC730B0AQ38520438-B5073382-C87E-4B34-B460-3B63DA300D91Q38909797-5746CEBB-8A7E-45F2-91B8-B4395E3632B4Q39256792-56FB31E7-C237-483F-9D2A-F00698DB7FF8Q39418832-AED131D6-B1B1-492D-AC83-AFBE7A5A52B4Q41525066-AA5A91CD-56C7-4373-8880-B34D111C48FAQ47239603-67092EF7-508E-4ADB-80DB-2D1D9EC451D9Q48482709-AEDC7C71-4C5F-4F2D-9AA7-4DE7E4E72091
P2860
How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
How genetics research in Parki ...... iopathic forms of the disease.
@ast
How genetics research in Parki ...... iopathic forms of the disease.
@en
type
label
How genetics research in Parki ...... iopathic forms of the disease.
@ast
How genetics research in Parki ...... iopathic forms of the disease.
@en
prefLabel
How genetics research in Parki ...... iopathic forms of the disease.
@ast
How genetics research in Parki ...... iopathic forms of the disease.
@en
P1476
How genetics research in Parki ...... iopathic forms of the disease.
@en
P2093
Georgia Xiromerisiou
P304
P356
10.1097/01.WCO.0000186841.43505.E6
P577
2005-12-01T00:00:00Z